ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1387	National Cancer Institute	Html	en	Breast Cancer Prevention (PDQ®)–Health Professional Version	Risk factors for breast cancer are female sex and advancing age, inherited risk, breast density, obesity, alcohol consumption, and exposure to ionizing radiation. Interventions to prevent breast cancer include chemoprevention (e.g. SERMs, AIs), risk-reducing surgery (e.g. mastectomy, oophorectomy). Review the evidence on risk factors and interventions to prevent breast cancer in this expert-reviewed summary.	Surgical Adjuvant Breast 0.484835 situ breast cancer 0.497037 Breast Cancer Intervention 0.493501 breast cancer trends 0.484079 breast cancer deaths 0.490132 radiation-associated breast cancer 0.489257 Engl J Med 0.493511 post-menopausal breast cancer 0.480461 Breast Cancer Surveillance 0.4815 breast cancer incidence. 0.495634 treatment-related breast cancer 0.489379 early-stage breast cancer 0.507669 fatal breast cancer 0.490061 ER-positive breast cancer 0.490928 breast cancer prevention 0.509672 Breast Cancer Collaborative 0.483305 breast cancer patients 0.502781 postmenopausal breast cancer 0.486608 therapy-related breast cancer 0.480826 breast cancer risk. 0.512722 Natl Cancer Inst 0.684414 -negative breast cancer 0.484014 breast cancer death 0.482095 invasive breast cancer 0.614612 et al. 0.488773	Swedish breast cancer 0.480364 women 0.553885 contralateral breast cancer 0.510667 early breast cancer 0.491581 age-specific breast cancer 0.483209 breast cancer susceptibility 0.482582 breast cancers 0.487583 age-adjusted breast cancer 0.485699 breast cancer rates 0.491912 human breast cancer 0.484504 tamoxifen breast cancer 0.487689 Female Breast Cancer 0.482581 postmenopausal women 0.549947 breast cancer risk 0.650399 International Breast Cancer 0.494317 Abstract 0.524687 breast cancer 0.96573 breast cancer mortality 0.521549 breast cancer cases 0.492675 Breast Cancer Study 0.481834 ER-negative breast cancer 0.487382 breast cancer incidence 0.616078 elevated breast cancer 0.489604 Excess breast cancer 0.489271	CLICK HERE
1401	National Cancer Institute	Html	en	Depression (PDQ®)–Patient Version	Expert-reviewed information summary about the diagnosis, assessment, and treatment of depression in adults and children who have cancer.	cancer treatment 0.651741 talk therapy 0.584553 cancer reacts 0.573578 PDQ cancer information 0.709592 specific symptoms 0.575944 children 0.567594 clinical trials 0.590596 major depression 0.717529 cancer information summary 0.661683 social support 0.596519 family members 0.586314 clinical trial 0.577701 breast cancer prevention 0.582269 risk factors 0.576392 cancer patients 0.640384 suicide 0.586542 cancer diagnosis 0.641499 daily life 0.565808 usual activities 0.591649 nerve cells 0.617277 symptoms 0.713409 NCI PDQ cancer 0.615822 anxiety 0.567307 effects 0.576095	treatment 0.684675 medicines 0.607072 Cancer Information Service 0.595317 personal history 0.608756 pancreatic cancer 0.571142 treatment clinical trials 0.568602 National Cancer Institute 0.658955 health care 0.575207 Palliative Care Editorial 0.599921 tricyclic antidepressants 0.564862 cancer pain 0.568074 new treatment 0.572603 Cancer Care page 0.585295 Care Editorial Board 0.601242 antidepressants 0.660082 active cancer treatment 0.606386 PDQ summary 0.608172 doctor 0.608478 cancer-related depression 0.600613 cancer information summaries 0.594088 comprehensive cancer information 0.593479 cancer 0.885163 depression 0.980341 reuptake inhibitors 0.578298	CLICK HERE
1503	National Cancer Institute	Html	en	Ovarian Germ Cell Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of ovarian germ cell tumors.	adjuvant chemotherapy 0.587693 pure dysgerminoma 0.480069 Oncology Group trials 0.399123 endodermal sinus tumor 0.426786 chemotherapy 0.67435 PDQ cancer information 0.453857 incompletely resected tumors 0.456006 cancer information summary 0.450698 high-dose chemotherapy 0.414186 recurrent germ cell 0.415503 durable remission 0.43875 radiographic procedures 0.437608 para-aortic lymph nodes 0.495597 patients 0.944817 intact ovary 0.411146 Surgical resection 0.432079 adjuvant therapy 0.398709 higher stage tumors 0.443399 total abdominal hysterectomy 0.474933 Gynecologic Oncology Group 0.490243 Endodermal sinus tumors 0.452987 radiation therapy 0.487845 immature teratoma 0.464025 modern chemotherapeutic era 0.398622 advanced stage dysgerminoma 0.404048	ovarian germ cell 0.413493 clinical examination 0.424181 primary tumor. 0.431827 residual masses 0.43388 well-staged patients 0.406144 fallopian tube 0.401507 completely resected tumors 0.468623 BEP combination chemotherapy 0.509951 cisplatin-based adjuvant treatment. 0.511465 maximal surgical debulking 0.469791 adjuvant setting 0.44443 endodermal sinus 0.463622 Second-look surgery 0.421726 disease 0.413051 large tumors 0.399492 mixed germ cell 0.430258 combination chemotherapy 0.637036 salvage therapy. 0.435874 cisplatin-containing combination chemotherapy 0.471327 stage IA tumors 0.445257 germ cell tumors 0.871083 stage 0.462819 initial surgical procedure 0.530199 Cisplatin-based combination chemotherapy 0.476734	CLICK HERE
1504	National Cancer Institute	Html	en	Carcinoma of Unknown Primary Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of metastatic cancer that has spread from an unidentified primary tumor.	prostate cancer-specific tests 0.758495 moderately differentiated tumors 0.76812 primary breast cancer 0.810157 CUP tumors 0.744436 germ cell tumor 0.900926 unguided clinical evaluation 0.74246 primary tumor origin. 0.829274 lung cancer 0.758661 major primary adenocarcinomas 0.79306 bone metastases 0.787576 CUP 0.964346 unguided radiographic studies 0.740775 patients 0.907112 poorly differentiated tumor 0.786876 poor prognostic finding. 0.745421 fine-needle aspiration biopsy 0.740303 axillary metastasis 0.759204 stage information section 0.75285 primary site 0.901386 primary malignancy 0.785612 primary disease 0.779121 lung metastases 0.79491 primary sites 0.766562 treatable primary cancers. 0.775244	CUP patients 0.753414 primary manifestation 0.731878 special diagnostic pathology 0.734268 Lymph node involvement 0.737229 pancreatic cancer 0.758796 Breast Cancer Treatment 0.769987 different metastatic distribution 0.743182 single study 0.73541 complete blood cell 0.762048 predominant bony distribution 0.735381 midline germ cell 0.743808 noncarcinoma cell type 0.749494 breast cancer 0.825399 certain clinical presentations 0.748925 primary tumor 0.992795 prostate cancer 0.879535 supradiaphragmatic primary malignancy 0.778764 significant prognostic importance 0.741352 potential primary lesion 0.812433 appropriate clinical evaluation 0.754068 occult primary tumor 0.820012 End Results data 0.738986 common primary carcinomas 0.811152 primary prostate cancer. 0.808097	CLICK HERE
1523	National Cancer Institute	Html	en	Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancer.	Peritoneal Cancer Prevention 0.227525 treatment 0.390762 cancer treatment 0.235396 Peritoneal Cancer Treatment 0.215309 cancer cells 0.337677 body 0.222684 PDQ cancer information 0.234419 ovarian epithelial cancer 0.590068 fallopian tube cancers 0.219247 fallopian tube 0.872006 advanced ovarian epithelial 0.202336 fallopian tube cancer 0.492956 National Cancer Institute 0.246576 primary peritoneal cancer 0.750448 clinical trials 0.486834	cancer information summary 0.212408 clinical trial 0.300455 new treatment 0.206874 PDQ Ovarian Epithelial 0.215884 ovarian cancer 0.427345 patients 0.208263 primary peritoneal cancers 0.298007 peritoneal cancer form 0.23692 Recurrent ovarian epithelial 0.234027 Hereditary ovarian cancer 0.23385 cancer clinical trials 0.21629 stage 0.222725 fallopian tubes 0.310827 cancer 0.950591 information 0.260881	CLICK HERE
1578	National Cancer Institute	Html	en	Salivary Gland Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of salivary gland cancer.	treatment 0.350503 cancer cells 0.273747 salivary gland tumors 0.252711 body 0.202362 Recurrent salivary gland 0.246617 PDQ cancer information 0.209396 clinical trial search 0.221183 National Cancer Institute 0.225088 clinical trials 0.502843 clinical trial 0.428553 fast neutron radiation 0.275402 patients 0.211575	salivary glands 0.27815 small salivary gland 0.219313 major salivary gland 0.219682 salivary gland cancer 0.977675 cancer clinical trials 0.23079 lymph node 0.201663 radiation therapy 0.594263 salivary gland cancers 0.255838 information 0.215378 diagnose salivary gland 0.246491 Minor salivary gland 0.204078 neutron radiation therapy 0.270686	CLICK HERE
1812	National Cancer Institute	Html	es	Tratamiento del linfoma no Hodgkin en adultos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del linfoma no Hodgkin en adultos.	low grade lymphomas 0.353173 indolent lymphoma 0.346062 non-Hodgkin's lymphoma patients 0.337212 American Lymphoma 0.327906 waldenstrom's macroglobulinemia 0.332106 Waldenström macroglobulinemia 0.338467 Cancer Lymphoma 0.327887 International Lymphoma Study 0.378433 células t 0.429883 Lymphoma Study Group 0.412935 lymphoma prognostic 0.326242 lymphoma during 0.331405 células pilosas 0.363214 working formulation 0.337079 Lymphoma Group 0.329696 or lymphoplasmacytic lymphoma 0.326933 Leuk Lymphoma 0.380736 patients with 0.413962 cell lymphoma 0.331134 international prognostic index 0.326792 indolent follicular lymphomas 0.348564 células cn 0.328794 células madre 0.372196 lymphoma undergoing autologous 0.331673 non-Hodgkin lymphoma 0.402286	diagnosed lymphoplasmacytoid lymphoma 0.32688 Non-Hodgkin's Lymphoma Classification 0.414101 lymphoma with 0.354845 indolent lymphoma with 0.335948 With Follicular Lymphoma 0.335376 follicular lymphoma based 0.329673 follicular lymphoma developed 0.329816 follicular lymphoma international 0.39904 Primary follicular lymphoma 0.331496 PDQ Tratamiento 0.434606 Lymphoma Myeloma Leuk 0.354464 follicular lymphoma 0.775836 Non-Hodgkin's Lymphoma Pathologic 0.332143 Clin Oncol 0.956456 lymphoma international prognostic 0.392841 Grade Lymphoma Study 0.333804 linfoma tlam 0.344251 bone marrow 0.327544 follicular lymphoma patients 0.364798 non-hodgkin's lymphoma 0.690487 waldenström's macroglobulinemia 0.329906 Lymphoma Classification Project 0.405984 linfoma folicular mixto 0.337045 lymphoma patients 0.381283	CLICK HERE
1826	National Cancer Institute	Html	es	Tratamiento del retinoblastoma (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del retinoblastoma en niños.	Fam Cancer 0.224979 second primary 0.226983 Moll AC 0.230701 bilateral retinoblastoma 0.377316 bilateral retinoblastoma treated 0.303483 Sin embargo 0.262098 cancers after radiotherapy 0.220083 with retinoblastoma 0.99058 retinoblastoma patients 0.504149 international classification 0.229832 hereditary retinoblastoma 0.609301 Imhof SM 0.218892 tumors among survivors 0.21889 with carboplatin 0.219119 retinoblastoma treated with 0.391051 retinoblastoma —una tasa 0.309551 gen rb1 0.264654 Estados Unidos 0.240611 Natl Cancer Inst 0.380536 patients with 0.285893 second malignant neoplasms 0.222801 ectopic intracranial retinoblastoma 0.30877 survivors treated with 0.222819 retinoblastoma survivors 0.803446 Retinoblastoma Families 0.301592	heritable retinoblastoma survivors 0.400266 long-term survivors 0.281356 orientación genética 0.258139 Abramson DH 0.390414 with retinoblastoma treated 0.311845 rb1 mutations 0.229834 sporadic unilateral retinoblastoma 0.309266 Retinoblastoma Survivor Study 0.395385 Second nonocular tumors 0.222288 Pediatr Blood Cancer 0.370166 retinoblastoma treated 0.437026 novel retinoblastoma 0.302896 Arch Ophthalmol 0.218403 International Retinoblastoma Staging 0.430669 sección retinoblastoma 0.316419 Clin Oncol 0.275713 sistema nervioso central 0.230398 tumor progresa 0.220651 Retinoblastoma Staging System 0.431448 among long-term survivors 0.238413 Shields CL 0.248375 retinoblastoma tumours 0.300442 Marees T 0.232711 retinoblastoma patients reveals 0.307846	CLICK HERE
1857	National Cancer Institute	Html	es	Tratamiento del cáncer escamoso metastásico de cuello con tumor primario oculto (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer escamoso metastásico de cuello con tumor primario oculto.	ominosa situación 0.323583 microscopic findings with 0.340934 poorly differentiated tumors 0.343157 cisplatin-based combination chemotherapy 0.340177 unknown primary site 0.370765 N)a aReproducción 0.321827 Instituto Nacional 0.378061 Radiat Oncol Biol 0.947729 bUna designación 0.320629 emission tomography with 0.337851 Diagn Pathol 0.32218 chemoradiotherapy using 0.320607 solid tumors 0.321716 Acta Cytol 0.320567 Head Neck Surg 0.377028 primary site 0.383303 after excisional biopsy 0.335976 metastases from 0.417556 dysfunction following radiotherapy 0.335828 carcinoma nasofaríngeo 0.419271 Kahn HJ 0.320427 paciente varón 0.325653 cervical lymph 0.356026 Recent progress 0.321743 intensity-modulated radiotherapy 0.356033	Cheung R 0.361917 from unknown primary 0.367172 National Cancer Institute 0.343401 PDQ Tratamiento 0.380147 nasopharyngeal carcinoma 0.428219 Lombardi Comprehensive Cancer 0.345987 Clin Oncol 0.335468 unknown primary 0.700357 Physician Data Query 0.330819 enfermedad n2 0.320558 Oncol Biol Phys 0.999042 enfermedad n1 0.322779 largo plazos 0.351849 metastatic adenocarcinomas 0.360803 unknown primary tumor 0.440765 Induction chemotherapy with 0.342645 Gray GF Jr 0.331989 neck cancer 0.546903 American Joint Committee 0.331644 Reimann BE 0.320391 Miyazaki I 0.364645 AJCC Cancer Staging 0.353491 squamous cell carcinoma 0.742589 solitary metastatic neck 0.365007	CLICK HERE
3879	National Cancer Institute	Html	es	Extractos de muérdago (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de los extractos de muérdago como tratamiento para personas con cáncer.	cuerpo frente 0.413451 Centro Nacional 0.449381 New Hampshire Avenue 0.415853 cabo ensayos 0.424385 Drug Administration 0.409825 NCI Best Case 0.428572 PDQ Extractos 0.439937 Helixor A 0.41291 datos bibliográficos pubmed 0.416761 marcas comerciales eurixor 0.426376 siguientes preguntas 0.410006 productos botánicos 0.410905 Polyerga Neu 0.415135 solicitudes ind 0.41359 cura lotodo 0.415539 vitamina b 0.413657 siguientes riesgos 0.412404 Instituto Nacional 0.532861 National Center 0.412812	siguientes marcas 0.416399 Salud Complementaria 0.466538 idioma alemán 0.413696 Visuals Online 0.41151 complementarias revisa 0.415619 Physician Data Query 0.465832 Estados Unidos 0.692378 mejores cuidados 0.41274 libre uso 0.41183 cabo estudios 0.418615 Integrative Health 0.413952 página manejo 0.410784 ¿El tratamiento 0.420943 ¿Los beneficios 0.40989 juntos cam 0.409184 respuesta corporal frente 0.42523 Series Program 0.409771 medicina complementaria 0.946895 árbol hospedador 0.450028	CLICK HERE